Publication | Closed Access

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

HemodialysisMedicineRenal PathologyParathyroid HormoneParathyroid DiseaseSide EffectsSequential ComparisonDialysis TherapyChronic Kidney DiseaseNephrologyDialysis Patients